Cargando…
Rho GTPases as therapeutic targets in cancer (Review)
Rho GTPases are key molecular switches controlling the transduction of external signals to cytoplasmic and nuclear effectors. In the last few years, the development of genetic and pharmacological tools has allowed a more precise definition of the specific roles of Rho GTPases in cancer. The aim of t...
Autores principales: | Cardama, G.A., Gonzalez, N., Maggio, J., Menna, P. Lorenzano, Gomez, D.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592879/ https://www.ncbi.nlm.nih.gov/pubmed/28848995 http://dx.doi.org/10.3892/ijo.2017.4093 |
Ejemplares similares
-
Rho GTPases as therapeutic targets in Alzheimer’s disease
por: Aguilar, Byron J., et al.
Publicado: (2017) -
Podocyte RhoGTPases: new therapeutic targets for nephrotic syndrome?
por: Saleem, Moin A., et al.
Publicado: (2019) -
Targeting Rho GTPase Signaling Networks in Cancer
por: Clayton, Natasha S., et al.
Publicado: (2020) -
Deregulation of Rho GTPases in cancer
por: Porter, Andrew P., et al.
Publicado: (2016) -
Extraction of active RhoGTPases by RhoGDI regulates spatiotemporal patterning of RhoGTPases
por: Golding, Adriana E, et al.
Publicado: (2019)